Nasal sprays are drug delivery devices used for treating nasal congestion by clearing nasal passages. Products like saline nasal sprays, steroid nasal sprays, antihistamine nasal sprays, and decongestant nasal sprays offer temporary relief from nasal congestion and are sold over-the-counter. Demand for nasal sprays is increasing as they are considered safe and effective in providing fast relief from nasal congestion and related symptoms like headaches and sinus pressure.
The global U.S. Nasal Spray Market is estimated to be valued at US$ 9903.35 Mn in 2023 and is expected to exhibit a CAGR of 6.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increasing demand for nasal congestion relief is driving innovations in nasal spray formulations. Many companies are focusing on developing nasal spray combinations involving multiple active ingredients. For instance, steroid-based nasal sprays are now available combined with antihistamines or decongestants, providing broader allergy and congestion relief from a single spray. Such combination nasal sprays have gained popularity as they effectively target multiple symptoms simultaneously without requiring users to use multiple products. This trend has made combination nasal sprays one of the fastest-growing segments. Further, companies are developing advanced spray technologies for improved targeting and delivery of ingredients to the nasal cavity for enhanced efficacy.
Segment Analysis
The U.S. nasal spray market is dominated by the decongestion sub-segment. Nasal decongestion sprays are used to temporarily relieve nasal congestion related to common cold, hay fever or other upper respiratory allergies. They work by constricting the blood vessels in the nasal passages, which helps promote better airflow and drainage of sinus cavities and sinuses. The decongestion sub-segment accounts for over 40% of the market share owing to high prevalence of nasal congestion issues among Americans and ready availability of these products over the counter without a prescription.
Key Takeaways
U.S. Nasal Spray Market Size is expected to witness high growth in the forecast period between 2023 to 2030. The market is expected to reach over US$ 9903.35 Mn by 2023, growing at a CAGR of 6.8% during the forecast period.
Regional analysis
The Western region accounts for the dominating share of over 35% in the U.S. nasal spray market. States like California, Washington and Oregon have higher prevalence of seasonal allergies and sinus issues owing to their climatic conditions. This is a key factor behind higher adoption and sales of nasal sprays in the Western region.
Key players
Key players operating in the U.S. nasal spray market are GlaxoSmithKline plc, Sanofi S.A., Bayer AG, Merck & Co., Inc., Novartis AG, Johnson & Johnson Services, Inc., Pfizer Inc., Procter & Gamble, AstraZeneca Plc., NeilMed Pharmaceuticals Inc., Church & Dwight Co., Inc., and Neurelis, Inc. GlaxoSmithKline plc holds the leading market share owing to its extensive product portfolio and wide distribution channel in the country.
Get More Insights on this Topic- https://www.rapidwebwire.com/nasal-spray-market-size-demand-and-growth/
